SS Innovations International (SSII) Cost of Revenue (2022 - 2026)
SS Innovations International (SSII) reported Cost of Revenue of $5.8 million for Q1 2026, up 43.16% on a YoY basis from $4.0 million in Q1 2025, and down 29.22% sequentially from $8.2 million in Q4 2025.
SS Innovations International (SSII) Cost of Revenue (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Cost of Revenue data on file, last reported at $5.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue rose 43.16% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $24.7 million (up 85.28% YoY), and the FY2025 full-year result was $22.9 million, up 88.08% from the prior year.
- Cost of Revenue fell to $5.8 million in Q1 2026, from $8.2 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $8.2 million in Q4 2025 to a low of $288773.0 in Q3 2022.
- A 5-year average of $3.2 million and a median of $2.9 million in 2024 frame the typical range for Cost of Revenue.
- Peak annual rise in Cost of Revenue reached 895.82% in 2024, while the deepest fall reached 9.58% in 2024.
- Tracing SSII's Cost of Revenue over 5 years: stood at $1.1 million in 2022, then jumped by 69.8% to $1.8 million in 2023, then soared by 124.74% to $4.1 million in 2024, then soared by 96.7% to $8.2 million in 2025, then declined by 29.22% to $5.8 million in 2026.
- Business Quant data shows SSII's Cost of Revenue at $5.8 million in Q1 2026, $8.2 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn | 5.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.77 Mn |
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 8.16 Mn |
| Dec 31, 2025 | 8.16 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 4.09 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 4.15 Mn |
| Dec 31, 2024 | 4.15 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 2.91 Mn |
| Mar 31, 2024 | 2.91 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Dec 31, 2023 | 1.85 Mn |